// App-Quantinova.ai

: A Single Center Experience of Transitioning Stable Pulmonary Arterial Hypertension Patients from Parenteral Prostacyclin Therapy to Oral Selexipag

Researchers

Presenter

  • T. G. Shah

Principal Investigators

  • O. Igenoza

  • S. Bartolome

  • F. Torres

  • M. Kingman

  • S. Harden

  • K. M. Chin

Medical Centers

  • Pulmonary and Critical Care Medicine, UT Southwestern Medical Center, Dallas, TX, United States,

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Pulmonary arterial hypertension

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Prostacyclin

  • Hydroxyzine

  • Selexipag

Outcome

  • N/A

Study Design

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved